ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 549 • 2012 ACR/ARHP Annual Meeting

    A Randomized, Open-Label Study of Maintenance of Partial Remission with Naproxen Vs No Treatment: Results of the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial, Part II

    Joachim Sieper1, Jan Lenaerts2, Jürgen Wollenhaupt3, Vadim Mazurov4, L. Myasoutova5, Sung-Hwan Park6, Yeong W. Song7, Ruji Yao8, Denesh Chitkara9 and Nathan Vastesaeger10, 1Charité, University Medicine Berlin, Berlin, Germany, 2Reuma-instituut, Hasselt, Belgium, 3Schön-Klinik, Hamburg, Germany, 4St. Petersburg Medical Academy, St. Petersburg, Russia, 5Kazan State Medical University, Kazan, Russia, 6Catholic University of Korea, Seoul, South Korea, 7Seoul National University, Seoul, South Korea, 8Merck Sharp & Dohme, Kenilworth, NJ, 9Merck Sharp and Dohme, Kenilworth, NJ, 10Merck Sharp & Dohme, Brussels, Belgium

    Background/Purpose: In patients with axial SpA who have achieved partial remission, it is unclear whether continuous treatment with NSAIDs is superior to stopping treatment. Objectives:…
  • Abstract Number: 550 • 2012 ACR/ARHP Annual Meeting

    Differences in the Prevalence of Inflammatory Articular Disease in Psoriatic Patients, Applying Clinical, Ultrasound and/or Radiological Data. Implications in the Classification of Psoriatic Arthritis according to Caspar Criteria

    Jose Luis Fernandez-Sueiro1, S. Pertega-Diaz2, JA Pinto1 and E. Gonzalez3, 1Rheumatology Division, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 2Epidemiology and Statistics, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 3Rheumatology, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain

    Background/Purpose: a)     To determine differences in the prevalence of inflammatory articular disease (IAD) in patients with cutaneous psoriasis when applying clinical, ultrasound (PDUS) or radiological…
  • Abstract Number: 510 • 2012 ACR/ARHP Annual Meeting

    IL-7 and IL-7 Receptor Blockade to Selectively Inhibit TLR7-Induced B Cell Activation in Primary Sjögren’s Syndrome

    A. Bikker1, C.R. Willis2, A.a. Kruize1, J.W.J. Bijlsma3, F.P.J.G. Lafeber3 and J.A.G. van Roon4, 1Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Amgen Inc., Seattle, WA, 3Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4Rheumatology & Clinical Immunology/Lab Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose:  Toll-like receptors (TLRs) are involved in the recognition of nucleic acids (viral, bacterial, and possibly self) and have been implicated in several auto-immune diseases.…
  • Abstract Number: 511 • 2012 ACR/ARHP Annual Meeting

    A New Pathogenic Role of Salivary Gland Epithelial Cells in the Costimulation of T Lymphocytes in Primary Sjögren’s Syndrome: 0X40 Ligand Expression, T-Cell Induction of OX40 and Promotion of T-Cell Survival, Proliferation and Activation

    Yazhuo Gong, Ghada Alsaleh, Jean Sibilia and Jacques-Eric Gottenberg, Université de Strasbourg, EA4438 Laboratoire Physiopathologie des Arthrites, Illkirch-Strasbourg, France

    Background/Purpose: OX40/OX40L interaction is a pivotal costimulatory pathway involved in multiple autoimmune diseases. It provides a key signal for T-cell proliferation and differentiation in effector…
  • Abstract Number: 512 • 2012 ACR/ARHP Annual Meeting

    Memory B Cell Phenotypic and Gene Expression Profiling in Primary Sjogren’s Syndrome: Implications for Disease Diagnosis

    Mustimbo E. P. Roberts1, Craig Maguire1, Alex Rosenberg2, Andreea Coca3, Jennifer H. Anolik4 and Inaki Sanz5, 1University of Rochester School of Medicine and Dentistry, Rochester, NY, 2University of Rochester, Rochester, NY, 3Univ of Rochester, Rochester, NY, 4Medicine- Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 5Medicine/Rheumatology, Rochester, Rochester, NY

    Background/Purpose: A paucity of known causative mechanisms in primary Sjögren’s Syndrome (pSS) contributes to inadequate classification criteria. However, known memory-phenotype B cell aberrations could enrich…
  • Abstract Number: 513 • 2012 ACR/ARHP Annual Meeting

    Regulatory B Cells in Primary Sjögren’s Syndrome

    Gabriela Hernandez-Molina1, Janette Furusawa-Carballeda1, Guadalupe Lima2, Yahaira Rivera1 and Luis Llorente3, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, 3Immunology and Rheumatology Department, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico

    Background/Purpose: B cells have traditionally been considered as positive regulators of humoral immune response, however their negative regulatory role has recently being recognized. Objective. To…
  • Abstract Number: 514 • 2012 ACR/ARHP Annual Meeting

    Frequencies and Numbers of Circulating IL-10 Producing Regulatory B Cells Are Not Disturbed in Pss-Patients but Correlate Negatively with the EULAR Sjögren Syndrome Disease Activity Score (ESSDAI)

    Wayel H. Abdulahad1, Gwenny Verstappen1, Arjan Vissink2, Minke G. Huitema1, Petra M. Meiners2, Hendrika Bootsma3 and Frans Kroese4, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, Netherlands, 3Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 4University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Recently, a specific and functionally important subset of regulatory B cells (Breg) that negatively regulate autoimmunity and inflammation has been described. Breg cells exert…
  • Abstract Number: 515 • 2012 ACR/ARHP Annual Meeting

    Stages of Sjogren’s Syndrome Defined by Immune Mediators

    Lakshmanan Suresh1, Julian Ambrus Jr.2 and Long Shen3, 1Laboratory Medicine, IMMCO Diagnostics Inc., Amherst, NY, 2Division of Allergy, Immunology and Rheumatology, Department of Medicine, State University of New York at Buffalo, Buffalo, NY, 3Department of Medicine, SUNY at Buffalo, Buffalo, NY

    Background/Purpose: Sjogren’s syndrome (SS) is characterized by destruction of the salivary and lachrymal glands but also systemic manifestations such as lung disease, kidney disease and…
  • Abstract Number: 516 • 2012 ACR/ARHP Annual Meeting

    Characterization of Dominant B- and Plasma Cell Clones in Patients with Primary Sjögren’s Syndrome and Patients with Sicca Syndrome

    Marieke E. Doorenspleet1, Erlin Haecke2, Paul L. Klarenbeek1, Annie Visser3, Rebecca E. Esveldt1, Fred Spijkervet4, Paul-Peter Tak5, Hendrika Bootsma6, Niek de Vries7 and Frans Kroese8, 1Division of Clinical Immunology and Rheumatology, Academic Medical Center of the University of Amsterdam, Amsterdam, Netherlands, 2Department of Rheumatology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 4Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, Netherlands, 5Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 6Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 7Division of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 8University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Primary Sjögren's syndrome (pSS) is an autoimmune exocrinopathy characterized by chronic inflammation and destruction of the salivary and lacrimal glands. Infiltration of B and…
  • Abstract Number: 517 • 2012 ACR/ARHP Annual Meeting

    Overexpression of BMP6 Is Associated with Loss of Salivary Gland Activity in Sjögren’s Syndrome Patients and Mice

    Hongen Yin1, Javier Cabrera-Perez1, Zhennan Lai1, Drew Michael2, Melodie Weller1, Bill Swaim1, Noreen Rana1, Xibao Liu1, Ilias Alevizos3, Indu Ambudkar4 and John A. Chiorini1, 1Mptb, NIH/NIDCR, Bethesda, MD, 2Mptb, NIDCR, Bethesda, MD, 3Sjogren's Clinic, NIDCR/ NIH #10 1N110, Bethesda, MD, 4Molecular Physiology and Therapeutics Branch, NIDCR, Bethesda, MD

    Background/Purpose: A hallmark of Sjögren’s syndrome (SS) is the loss of activity in secretory epithelia, specifically the larcrimal and salivary glands. The mechanism(s) driving this…
  • Abstract Number: 518 • 2012 ACR/ARHP Annual Meeting

    Spontaneous Sialadenitis Like Sjögren’s Syndrome in Orphan Nuclear Receptor γt (RORγt) Transgenic Mice

    Mana Iizuka1, Hiroto Tsuboi1, Hiromitsu Asashima1, Yuya Kondo1, Satoru Takahashi2, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: The nuclear receptors retinoic-acid-receptor-related orphan receptors gt (RORγt) is required for the generation of Th17 cells expressing the proinflammatory cytokine IL-17. Th17 cells expressing…
  • Abstract Number: 519 • 2012 ACR/ARHP Annual Meeting

    Sex-Specific Regulatory T Cell Dysfunction in a Mouse Model of Sjögren Syndrome

    Scott M. Lieberman1, Portia A. Kreiger2 and Gary A. Koretzky3, 1Pediatrics, Div Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Pathology, Nemours/A.I. DuPont Hospital for Children, Wilmington, DE, 3Medicine, University Pennsylvania, Philadelphia, PA

    Background/Purpose: CD4+Foxp3+ regulatory T cells (Tregs) are a specialized population of lymphocytes which prevent autoimmunity in normal hosts. Treg dysfunction has been implicated in autoimmunity; however results…
  • Abstract Number: 520 • 2012 ACR/ARHP Annual Meeting

    Genetic Associations to Germinal Centre Formation in Primary Sjögren’s Syndrome

    Tove Ragna Reksten1, Malin V. Jonsson2, Roland Jonsson1, Gunnel Nordmark3 and The Swedish-Norwegian Sjögren's syndrome Network4, 1Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway, 2Department of Clinical Dentistry - Section for Oral and Maxillofacial Radiology, University of Bergen, Bergen, Norway, 3Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 4Bergen

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is an autoimmune rheumatic disease mainly affecting the salivary and lacrimal glands causing xerostomia and keratoconjunctivitis sicca. Focal mononuclear cell…
  • Abstract Number: 521 • 2012 ACR/ARHP Annual Meeting

    Differences in Genome-Wide DNA Methylation Profiles Across Multiple Cell and Tissue Types in Sjögren’s Syndrome (SS)

    Lindsey A. Criswell1, Diana Quach2, Hong L. Quach2, Emon Elboudwarej2 and Lisa F. Barcellos2, 1Rosalind Russell Medical Research Center for Arthritis, Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, CA, 2Epidemiology, University of California, Berkeley, Berkeley, CA

    Background/Purpose: Increasing evidence supports a role for epigenetic factors, including DNA methylation status, in autoimmune disease risk and severity. Our goal is to characterize DNA…
  • Abstract Number: 522 • 2012 ACR/ARHP Annual Meeting

    Genetic Variation in the NCR3 Locus Is Associated with Anti-SSA⁄SSB Positive Primary Sjögren′s Syndrome in Scandinavian Samples

    Gunnel Nordmark1, Maija-Leena Eloranta1, Per Eriksson2, Elke Theander3, Helena Forsblad-d'Elia4, Roald Omdal5, Marie Wahren-Herlenius6, Roland Jonsson7 and Lars Rönnblom1, 1Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 2Rheumatology/AIR, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, 3Dept of Rheumatology, Skane University Hospital, Lund University, Malmö, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 5Department of Internal Medicine, Stavanger university Hospital, Stavanger, Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 6Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 7Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway

    Background/Purpose: Candidate gene studies in primary Sjögren’s syndrome (pSS) have identified polymorphisms in genes involved in the type I interferon (IFN) system and the type…
  • « Previous Page
  • 1
  • …
  • 2566
  • 2567
  • 2568
  • 2569
  • 2570
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology